The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery?
G G
GG
Whitlock
A
A
Patel
S G
SG
Edwards
P D
PD
Benn
R F
RF
Miller
D000328:Adult; D000730:Androstadienes / Q000008:administration & dosage / Q000493:pharmacokinetics; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D019033:Delivery of Health Care, Integrated / Q000458:organization & administration*; D019468:Disease Management; D004347:Drug Interactions; D000068298:Fluticasone; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D033183:Interdisciplinary Communication; D008297:Male
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D044966:Anti-Retroviral Agents; D000960:Hypolipidemic Agents; D000068298:Fluticasone